Allison E. Norlander, PhD

Bio

Allison E. Norlander, PhD, is an Assistant Professor in the Department of Anatomy, Cell Biology, and Physiology with a joint appointment in the Krannert Cardiovascular Research Center at Indiana University School of Medicine. Dr. Norlander received her bachelor’s degree from the University of Pittsburgh and subsequently completed her PhD at Vanderbilt University. Dr. Norlander completed her postdoctoral fellowship at Vanderbilt University Medical Center. Dr. Norlander’s work focuses on the study of T cells in inflammation. She has several projects focusing on understanding the impact of PGI₂ on T cells in Allergic Airway Inflammation and Hypertension.

Read more about the Norlander Lab!

Key Publications

Norlander AE, Bloodworth MH, Toki S, Zhang J, Zhou W, Boyd KL, Polosukhin VV, Cephus JY, Ceneviva ZJ, Gandhi VD, Chowdhury NU, Charbonnier LM, Rogers LM, Wang J, Aronoff DM, Bastarache L, Newcomb DC, Chatila TA, Peebles RS Jr. Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming. The Journal of Clinical Investigation. 2021 February 2. PMID: 33529171

Norlander AE, Saleh MA, Itani HA, Pandey AK, Wu J, Xiao L, Dale BL, Harrison DG, Madhur MS. T cell Specific Deletion of Serum and Glucocorticoid-Regulated Kinase 1 Attenuates Hypertension and End-Organ Inflammation. JCI Insight. 2017 July 6. PMID: 28679951.

Norlander AE, Saleh MA, Kamat N, Ko B, Gnecco J, Zhu L, Dale B, Iwakura Y, Hoover R, McDonough A, Madhur MS. Interleukin 17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II- Induced Hypertension. Hypertension. 2016 May 2. PMID: 27141060.

Titles & Appointments

Assistant Professor of Anatomy, Cell Biology & Physiology

Education

2017 PhD Vanderbilt University

2012 BS University of Pittsburgh
Research

See more here!!! Norlander Lab

Hypertension, defined as blood pressure ≥ 130/80 mmHg, has become a worldwide health concern, and affects 46% of adults in the United States. Recent studies have linked the immune system to the development and pathogenesis of hypertension. Generation of tolerance to self and the promotion of anti-inflammatory pathways are potential avenues for the development of drugs to treat of hypertension.

In the last 50 years, allergic diseases such as allergic rhinitis (runny nose), asthma, food allergy, and atopic eczema (skin allergy) have been spreading rapidly. Allergen tolerance can be considered as a non-pathogenic immune response to allergen. Discovery of factors that promote tolerance to an allergy or that promote an anti-inflammatory response, are critical to reverse the increasing number and severity of allergic diseases.

Therefore, better understanding the inflammatory and immune-mediated mechanisms promoting disease pathogenesis could result in the development of drugs to treat allergy, asthma, and/or hypertension.

The Norlander Lab evaluates human cells from patients with disease and utilizes mouse models that recapitulate disease to better understand cell-type functionality, pathway alterations, and treatments of interest. Specifically, the lab is currently interested in understanding how PGI₂ or Prostaglandin I₂ is augmenting T regulatory cell and T follicular helper cell function in hypertension and allergy/asthma.

Research Labs

Faculty research at IU School of Medicine is transforming health. Details about the medical research being conducted in faculty labs throughout IU School of Medicine are available in the Research section of this site.

Faculty Labs